{
  "issued_date": "2012-01-23", 
  "original_url": "http://www.mhra.gov.uk/Publications/Safetywarnings/DrugAlerts/CON140798", 
  "doc_details": {
    "Type": "Drug Alert", 
    "Series No": "EL (12)A/04", 
    "Audience": "Healthcare professionals", 
    "Published": "23 January 2012", 
    "Format": "Electronic only", 
    "Size": "A4", 
    "Pages": "1", 
    "Price": "Free", 
    "ISBN/ISSN": "None", 
    "Author": "", 
    "Copyright": "Crown"
  }, 
  "_assets": [
    {
      "content_type": "application/pdf", 
      "title": " Drug safety information: MHRA safety information for Vigantoletten (1000 IU Colecalciferol) Tablets (EL (12)A/04) (49Kb)", 
      "assetid": 0, 
      "original_url": "http://www.mhra.gov.uk/home/groups/is-md/documents/websiteresources/con140800.pdf", 
      "filename": "downloads/b34c221fa366cddc6287e74f82dae4eb3781c2f7/con140800.pdf", 
      "original_filename": "con140800.pdf"
    }
  ], 
  "body": "## DRUG ALERT\n\nDrug safety information\n\nFor immediate dissemination during working hours\n\n  \n  \n  \n23 January 2012  |   |  EL (12)A/04  |   |  Our ref:\u00a0 MDR 40-01/12   | \n\n* * *\n\nDear Healthcare Professional,\n\nMerck Serono, Germany\n\nVigantoletten (1000 IU Colecalciferol) Tablets\n\nThe above unlicensed product is imported in significant quantities into the UK.\n\nImporters of medicines that are unlicensed in the UK must notify the MHRA in accordance with [The Medicines for Human Use (Manufacturing, Wholesale Dealing and Miscellaneous Amendments) Regulations 2005/2789](http://www.legislation.gov.uk/uksi/2005/2789/contents/made) (external link). For further information, please see also [Guidance Note 14](http://www.mhra.gov.uk/home/idcplg?IdcService=GET_FILE&dDocName=CON007547&RevisionSelectionMethod=Latest).\n\nNotifications for importation of unlicensed medicines are assessed by the MHRA and objections may be raised where there are prohibitive safety or quality concerns, or in the case of non-objections to import, advice issued where users need to be aware of safety or quality issues.\n\nAlthough importers are advised that the prescriber must be made aware that Vigantoletten tablets contain soya oil, and are contraindicated for patients with allergies to this ingredient, it has come to the attention of the MHRA that not all users may be aware of these safety issues. This is of particular concern because packs and leaflets are in the German language. Although there is currently no legal requirement for imported medicines to be labelled in English, the expectation in the National Health Service is that suitable English language labelling will be provided as a matter of good practice. \u00a0\u00a0NHS guidance has been issued which reflects this.\n\nAllergy to soya oil may lead to severe allergic reactions including anaphylaxis. Recipients are therefore asked to bring this information to the attention of relevant professionals.\n\nYours faithfully,  \nGraham Matthews  \nSenior Pharmaceutical Assessor, Unlicensed Medicines\n\nMHRA Distribution (further recipients by cascade):  Regional contacts for NHS trusts and provider units  \nChief pharmacists: England, Scotland, Wales, Northern Ireland  \nPrison Health Policy Unit (DH)  \nChief pharmacists: \u00a0Jersey, Guernsey, Alderney, Sark, Isle of Man, Gibraltar  \nSpecial Hospitals  \nCare Quality Commission for distribution to Independent Health Care Establishments  \nPrimary care trusts (England) \n\n### Download documents:  \n  \n  * [ASSET_TAG](#ASSET0)\n", 
  "raw_html": "<div class=\"inner\">          \r\n\t\t\t\t<a name=\"main\"></a>\r\n\t\t\t\t\r\n\t\t\t\t<div class=\"title\">\r\n\t\t\t\t\t<h2>DRUG ALERT</h2>\r\n\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element14)-->\r\n\t\t\t\t\t<p>Drug safety information</p>\r\n\t\t\t\t\t<!--SS_END_ELEMENT(region1_element14)-->\r\n\t\t\t\t</div>\r\n\t\t\t\t\r\n\t\t\t\t<div class=\"drugalertdetails\">\r\n\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element15)-->\r\n\t\t\t\t\t<p>For immediate dissemination during working hours</p>\r\n\t\t\t\t\t<!--SS_END_ELEMENT(region1_element15)-->\r\n\t\t\t\t\t<br>\r\n\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element16)-->\r\n\t\t\t\t\t\r\n\t\t\t\t\t<!--SS_END_ELEMENT(region1_element16)-->\r\n\t\t\t\r\n\t\t\t\t\t<table id=\"dateref\">\r\n\t\t\t\t\t\t<tr>\r\n\t\t\t\t\t\t\t<td align=\"left\">\r\n\t\t\t\t\t\t\t\r\n\r\n\t\t\t\t\t\t\t23 January 2012\r\n\t\t\t\t\t\t\t</td>\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t<td>\r\n\t\t\t\t\t\t\tEL (12)A/04\r\n\t\t\t\t\t\t\t</td>\r\n\t\t\t\t\t\t\t\r\n\t\t\t\t\t\t\t<td align=\"right\">\r\n\t\t\t\t\t\t\t\tOur ref:&#160;\r\n\t\t\t\t\t\t\t\t<!--SS_BEGIN_ELEMENT(region1_element17)-->\r\n\t\t\t\t\t\t\t\t MDR 40-01/12 \r\n\t\t\t\t\t\t\t\t<!--SS_END_ELEMENT(region1_element17)-->\r\n\t\t\t\t\t\t\t</td>\r\n\t\t\t\t\t\t</tr>\r\n\t\t\t\t\t</table>\r\n\t\t\t\t</div>\r\n\t\t\t\t<hr>\t\t\t\t\r\n          \t\t<!--SS_BEGIN_ELEMENT(region1_element12)-->\r\n          \t\t<!--SS_END_ELEMENT(region1_element12)--> \r\n          \t\t\r\n          \t\t \r\n          \t\t\r\n          \t\t<p>Dear Healthcare Professional,</p>\r\n\r\n\t\t\t\t<div class=\"druginfo\">\r\n\t\t\t\t\t<div class=\"left\">\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t<p>\r\n\t\t\t\t\t\t\t<span>Merck Serono, Germany</span>\r\n\t\t\t\t\t\t</p>\r\n\t\t\t\t\t\t\t\t\t\t\r\n          \t\t          \t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t<p>\r\n\t\t\t\t\t\t\t<span>Vigantoletten (1000 IU Colecalciferol) Tablets</span>\r\n\t\t\t\t\t\t</p>\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t</div>\r\n\t\t\t\t\t\r\n\t\t\t\t\t<div class=\"right\">\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t\t\r\n\t\t\t\t\t</div>\t\r\n\t\t\t\t</div>\t\t\t\t\r\n          \t\t\r\n\t\t\t\t<!-- SS_BEGIN_SNIPPET(fragment8,navigation_controls)-->\r\n\t\t\t\t<!-- only show the publication navigation controls if there is more than one page to the publication -->\r\n\t\t\t\r\n\t\t\t\t<!-- SS_END_SNIPPET(fragment8,navigation_controls)-->\r\n \t\t\r\n\t\t\t\t<!-- SS_BEGIN_SNIPPET(region1_element2,paged_publication)-->\r\n        \t\t<!-- <br>SS_DATAFILE: CON140798 -->\r\n\r\n\t\t\t\t\t\r\n\r\n<!-- call include to dynamically insert alt attributes into image tags within a wysiwyg element -->\r\n<!-- get a reference to the wysiwyg content -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<!-- parse hyperlinked images -->\r\n<!-- parse word documents -->\r\n<!-- parse powerpoint documents -->\r\n<!-- parse excel documents -->\r\n<!-- parse pdf documents -->\r\n<!-- parse links to the site -->\r\n<!-- remove all hardlinks to cms -->\r\n<!-- replace /stellent/ with current webroot -->\r\n<p></p><p>The above unlicensed product is imported in significant quantities into the UK.</p>\n\n<p>Importers of medicines that are unlicensed in the UK must notify the MHRA in accordance with <a target=\"_blank\" href=\"http://www.legislation.gov.uk/uksi/2005/2789/contents/made\">The Medicines for Human Use (Manufacturing, Wholesale Dealing and Miscellaneous Amendments) Regulations 2005/2789</a> (external link). For further information, please see also <a href=\"http://www.mhra.gov.uk/home/idcplg?IdcService=GET_FILE&amp;dDocName=CON007547&amp;RevisionSelectionMethod=Latest\">Guidance Note 14</a>.</p>\n\n<p>Notifications for importation of unlicensed medicines are assessed by the MHRA and objections may be raised where there are prohibitive safety or quality concerns, or in the case of non-objections to import, advice issued where users need to be aware of safety or quality issues.</p>\n\n<p>Although importers are advised that the prescriber must be made aware that Vigantoletten tablets contain soya oil, and are contraindicated for patients with allergies to this ingredient, it has come to the attention of the MHRA that not all users may be aware of these safety issues. This is of particular concern because packs and leaflets are in the German language. Although there is currently no legal requirement for imported medicines to be labelled in English, the expectation in the National Health Service is that suitable English language labelling will be provided as a matter of good practice. &#160;&#160;NHS guidance has been issued which reflects this.</p>\n\n<p>Allergy to soya oil may lead to severe allergic reactions including anaphylaxis. Recipients are therefore asked to bring this information to the attention of relevant professionals.</p>\n\n<p>Yours faithfully,<br>\nGraham Matthews<br>\nSenior Pharmaceutical Assessor, Unlicensed Medicines</p>\r\n\r\n\t\t\t\r\n        \t\t<!-- SS_END_SNIPPET(region1_element2,paged_publication)-->\r\n        \t\t\r\n        \t\tMHRA Distribution (further recipients by cascade):\r\n        \t\t\r\n        \t\t <!--SS_BEGIN_ELEMENT(region1_element18)-->\r\n        \t\tRegional contacts for NHS trusts and provider units<br>\nChief pharmacists: England, Scotland, Wales, Northern Ireland<br>\nPrison Health Policy Unit (DH)<br>\nChief pharmacists: &#160;Jersey, Guernsey, Alderney, Sark, Isle of Man, Gibraltar<br>\nSpecial Hospitals<br>\nCare Quality Commission for distribution to Independent Health Care Establishments<br>\nPrimary care trusts (England)\r\n        \t\t<!--SS_END_ELEMENT(region1_element18)-->\r\n \t\t\r\n\t\t\t\t<!-- SS_BEGIN_SNIPPET(region1_element3,static_pdf_list)-->\r\n        \t\t<!-- the xmlListTag variable is used by the searchDocsByContentIdList include to map the name of the XML node which contains the content id -->\r\n<!--perform the search -->\r\n\t\r\n\t<!-- <br>root: Content/AssociatedContent -->\r\n\t<!-- <br>ssFragmentInstanceId: region1_element3\t -->\r\n\t<!-- <br>SS_DATAFILE: CON140798 -->\r\n\t<!-- <br>xmlListTag: ContentId\t -->\r\n\t<!-- <br>XPATH: CON140798/Content/AssociatedContent/ContentId\t -->\r\n\r\n\t<!-- xmlListTag variable should be the name of the xml node which contains a contentid.  there should be a lis of these in the XML -->\r\n\t<!-- <br>strNumRecords: 1 -->\r\n\t<!-- <br>nNumRecords: 1 -->\r\n\r\n\t\t\t<!-- using the content ID above, get the docment from conetent server-->\r\n\r\n\t\t\t\r\n\r\n\t\t<!--  dDocName <matches>`CON140800` -->\r\n\t\t\r\n<div id=\"downloadArea\">\r\n\t<h3>Download documents:</h3>\r\n\t<ul>\r\n\t\t<!-- the SearchResults will have been initialised by the call to searchDocsByContentIdList above-->\r\n\t\t\t\r\n\t\t\t\t<li>\r\n\r\n\t\t\t\t\t\t<a href=\"#ASSET0\">ASSET_TAG</a>\r\n\t\t\t\t</li>\r\n\t</ul>\r\n\t<div class=\"clearing\"><!--  --></div>\r\n\t<!--<p><a class=\"doubleArrow\" target=\"new\" href=\"http://www.adobe.com/products/acrobat/readstep2.html\">Download Acrobat Reader for free</a></p>\r\n\t<p><a class=\"doubleArrow\" target=\"new\" href=\"http://www.adobe.com/products/acrobat/access_onlinetools.html\">Adobe text conversion tools</a></p>-->\r\n</div>\r\n\t\t\t\r\n        \t\t<!-- SS_END_SNIPPET(region1_element3,static_pdf_list)-->\r\n \t\t\r\n\t\t\t\t<!-- SS_BEGIN_CLOSEREGIONMARKER(region1)-->\r\n        \t\t\r\n        \t\t<!-- SS_END_CLOSEREGIONMARKER(region1)-->\r\n\t\t\t</div>\r\n\t\t", 
  "title": "Drug safety information - MHRA safety information for Vigantoletten (1000 IU Colecalciferol) Tablets - (EL (12)A/04)", 
  "alert_type": [
    "drugs"
  ], 
  "medical_specialism": []
}